America’s access to medicine is under threat.

Traditional Supply Chains Have Fractured
The reliable flow of essential medicines into the U.S. has been irrevocably ruptured by the Covid-19 pandemic.
Outdated Manufacturing Techniques Have Caused Damage
The batch manufacturing practices widely used today devastate the environment and increase our reliance on foreign sources.
Drug Safety and Quality Have Been Compromised
The use of cheap and toxic additives lowers the efficacy of our medicines and jeopardizes the welfare of consumers.

Bright Path is committed to creating a secure and sustainable supply chain that provides every patient with access to safe and affordable medicines.

Bright Path Laboratories Videos

BrightPath on Yahoo Finance - Video